(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OVIXAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OVIXAN

ST13

US500000079278867

Class

5

Filing

79278867

Registration

6132808

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

08/26/2025

Trademark type

Word

Nice classes

5

Filing date

12/23/2019

Registration date

08/25/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/25/2020

Last transaction

08/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

64

Owner location

SE

Examiner

AGREDA, SAMANTHA

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Galenica AB

Representatives

M. Scott Alprin Alprin Law Offices, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the immune systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; pharmaceutical and veterinary preparations for the treatment of inflammatory disorders; pharmaceutical and veterinary preparations for use in dermatologyoncologyhematologyin tissue and organ transplantationfor gastroenterological disorders; sanitary preparations for medical purposes; food for babies; medical plasters; medical dressings; material for stopping teethdental wax; all purpose disinfectants; preparations for destroying vermin; fungicidesherbicides; all of the foregoing excluding pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and of disorders of the nervous systemexcluding antidepressant pharmaceutical preparationsall of the aforementioned goods not for diagnostic use

Publications

History of USPTO decisions and trademark events.

24 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/25/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/04/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/03/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/15/2020

FIMP

FINAL DISPOSITION PROCESSED

12/15/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/25/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

08/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/09/2020

PUBO

PUBLISHED FOR OPPOSITION

06/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2020

RFNT

REFUSAL PROCESSED BY IB

05/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/30/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/29/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/29/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/29/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/15/2020

RFRR

REFUSAL PROCESSED BY MPU

04/14/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/28/2020

CNRT

NON-FINAL ACTION WRITTEN

03/27/2020

DOCK

ASSIGNED TO EXAMINER

03/19/2020

MAFR

APPLICATION FILING RECEIPT MAILED

02/25/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/21/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/18/2020

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

02/13/2020

Continuous trademark protection

Get notified about every new filing that threatens OVIXAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.